The CompleteGym PeptideStack

CJC-1295/Ipamorelin has two optimal timing windows. For pre-workout use, inject 45–60 minutes before training on an empty stomach — this drives a GH pulse that improves performance, energy, and training capacity during the session. For maximum GH amplification, the pre-sleep protocol (immediately before bed, fasted) targets the nocturnal GH pulse which is the primary anti-aging and muscle-building window. Many users run CJC/Ipa pre-sleep daily and add a pre-workout injection on training days for a dual-pulse protocol.

BPC-157 is most effective when injected near the area of acute soreness or injury — subcutaneous injection within 2–3 cm of the affected tendon, muscle, or joint. For general gym recovery (no specific injury), abdominal subcutaneous injection provides systemic distribution. TB-500 is always injected subcutaneously for systemic delivery — it acts via stem cell mobilization that reaches all injury sites simultaneously. The classic gym recovery protocol: BPC-157 250–500 mcg daily near the primary training site + TB-500 2.5 mg twice per week for systemic coverage.

IGF-1 LR3 is the most potent legal muscle-building peptide available. It binds IGF-1 receptors on muscle satellite cells (the stem cells of muscle tissue), driving both hyperplasia (new muscle fiber formation) and hypertrophy (existing fiber growth). Unlike exogenous IGF-1, the LR3 variant has a 20–30 hour half-life and a reduced affinity for IGF-binding proteins — meaning more free, active IGF-1 reaching muscle tissue. A 4-week cycle at 50–80 mcg daily produces lean mass gains that are difficult to achieve any other way without pharmaceutical anabolics.

Yes — Tirzepatide and CJC/Ipamorelin work via completely different mechanisms and are highly complementary. Tirzepatide reduces appetite and improves insulin sensitivity via GIP/GLP-1 receptor agonism. CJC/Ipa elevates growth hormone, which directly inhibits fat storage and drives lipolysis. Together they create a powerful dual-mechanism fat loss environment: less energy in (Tirzepatide) plus more fat mobilization (GH axis optimization). The combination produces significantly better body composition outcomes than either alone.

It depends on the peptide. BPC-157 and TB-500 can be run continuously or cycled as needed — they do not downregulate their own receptors. CJC-1295/Ipamorelin is typically cycled 5 days on / 2 off to prevent pituitary desensitization, or run continuously at lower doses. IGF-1 LR3 should be cycled more strictly — 4 weeks on, 2 weeks off minimum — as sustained IGF-1 receptor stimulation can desensitize receptors and has theoretical implications for cellular proliferation. Tirzepatide is designed for continuous use.

The Starter Stack (CJC/Ipamorelin + BPC-157) focuses on the two highest-leverage interventions: GH axis optimization and recovery acceleration. For most gym-goers, these alone produce dramatic improvements in recovery speed, body composition, and training capacity. The Intermediate Stack adds IGF-1 LR3 for direct muscle-building signaling. The Advanced Stack layers in Tirzepatide for fat loss and optimizes the GH timing protocol with a dual-pulse approach. Each tier builds on the previous — start with the Starter Stack and add layers as you learn how your body responds.

Training days: Pre-workout CJC/Ipa 45–60 min before training (fasted). BPC-157 near training site post-workout. Pre-sleep CJC/Ipa right before bed. Rest days: Pre-sleep CJC/Ipa only (one injection). BPC-157 maintenance dose for recovery. TB-500 twice per week regardless of training schedule. IGF-1 LR3: inject on training days within 30 minutes of training for best muscle uptake, but daily injection during the cycle is also effective.